Effects of cholecystokinin octapeptide on the exocrine pancreas in a new rat model of type 2 diabetes

European Journal of Pharmacology

Volumn 448, Issue 2-3, 2002, Pages 253-261

  Kuntz, Emmanuelle ^a   Pinget, Michel ^a   Damgé, Christiane ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Affinity binding site; Cholecystokinin; Diabetes; Pancreas

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; BROXURIDINE; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; NICOTINAMIDE; STREPTOZOCIN;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BINDING SITE; CELL CULTURE; CELL ISOLATION; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; IN VITRO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGAN GROWTH; PANCREAS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STREPTOZOCIN DIABETES; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMAL; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; ORGAN WEIGHT; PANCREAS; RATS; RATS, WISTAR; RECEPTORS, CHOLECYSTOKININ; SINCALIDE; ANIMALS; DIABETES MELLITUS, TYPE 2; ORGAN SIZE;

EID: 0037135038     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01937-4     Document Type: Article

References (34)

1. Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes
2. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth
3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
4. Biological actions of cholecystokinin
5. Techniques for measuring amylase secretion from pieces of mouse pancreas
6. The effect of cholecystokinin in controlling appetite and food intake in humans
7. Purification and characterization of the rat pancreatic cholecystokinin receptor
8. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor
9. Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat
10. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat
11. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain
12. Evaluation of pancreatic exocrine function using pure pancreatic juice in noninsulin-dependent diabetes mellitus
13. Pancreatic islet-acinar cell interaction: Amylase messenger RNA levels are determined by insulin
14. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction
15. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260
16. Characterization of a new CCK antagonist, L364,718: In vitro and in vivo studies
17. Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide
18. Decreased pancreatic exocrine response to cholecystokinin in Zucker obese rats
19. Cholecystokinin and satiety: Current perspectives
20. Disordered food intake and obesity in rats lacking cholecystokinin A receptors
21. Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes
22. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors
23. A reduced pancreatic protein secretion in response to cholecystokinin (CCK) in the obese Zucker rat correlates with a reduced receptor capacity for CCK
24. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA
25. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini
26. Determination of nucleic acids in tissues by pentose analysis
27. Pancreatic insulin release and peripheral tissue resistance in Zucker obese rats fed high- and low-carbohydrate diets
28. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats
29. Studies on the determination of lipase activity
30. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans
31. Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini
32. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas
33. Pancreatic receptors for cholecystokinin: Evidence for three receptor classes
34. Hereditary obesity in the rat associated with hyperlipemia